| Literature DB >> 34876604 |
Mitesh Patel1, Maria H Nilsson2,3,4, Stig Rehncrona5, Fredrik Tjernström6, Måns Magnusson6, Rolf Johansson7, Per-Anders Fransson8.
Abstract
Parkinson's disease (PD) is characterized by rigidity, akinesia, postural instability and tremor. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) reduces tremor but the effects on postural instability are inconsistent. Another component of postural control is the postural strategy, traditionally referred to as the ankle or hip strategy, which is determined by the coupling between the joint motions of the body. We aimed to determine whether DBS STN and vision (eyes open vs. eyes closed) affect the postural strategy in PD in quiet stance or during balance perturbations. Linear motion was recorded from the knee, hip, shoulder and head in 10 patients with idiopathic PD with DBS STN (after withdrawal of other anti-PD medication), 25 younger adult controls and 17 older adult controls. Correlation analyses were performed on anterior-posterior linear motion data to determine the coupling between the four positions measured. All participants were asked to stand for a 30 s period of quiet stance and a 200 s period of calf vibration. The 200 s vibration period was subdivided into four 50 s periods to study adaptation between the first vibration period (30-80 s) and the last vibration period (180-230 s). Movement was recorded in patients with PD with DBS ON and DBS OFF, and all participants were investigated with eyes closed and eyes open. DBS settings were randomized and double-blindly programmed. Patients with PD had greater coupling of the body compared to old and young controls during balance perturbations (p ≤ 0.046). Controls adopted a strategy with greater flexibility, particularly using the knee as a point of pivot, whereas patients with PD adopted an ankle strategy, i.e., they used the ankle as the point of pivot. There was higher flexibility in patients with PD with DBS ON and eyes open compared to DBS OFF and eyes closed (p ≤ 0.011). During balance perturbations, controls quickly adopted a new strategy that they retained throughout the test, but patients with PD were slower to adapt. Patients with PD further increased the coupling between segmental movement during balance perturbations with DBS ON but retained a high level of coupling with DBS OFF throughout balance perturbations. The ankle strategy during balance perturbations in patients with PD was most evident with DBS OFF and eyes closed. The increased coupling with balance perturbations implies a mechanism to reduce complexity at a cost of exerting more energy. Strategic alterations of posture were altered by DBS in patients with PD and were delayed. Our findings therefore show that DBS does not fully compensate for disease-related effects on posture.Entities:
Mesh:
Year: 2021 PMID: 34876604 PMCID: PMC8651728 DOI: 10.1038/s41598-021-02813-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
DBS, vision and adaptation effects on the body movement pattern.
| GLM ANOVA Statistics*,** | DBS | Vision | Adaptation | DBS × Vision | DBS × Adaptation | Vision × Adaptation | DBS × Vision × Adaptation |
|---|---|---|---|---|---|---|---|
| Head–Shoulder | 0.711 (0.2) | 0.352 (1.0) | 0.437 (0.7) | 0.395 (0.8) | 0.120 (3.3) | 0.353 (1.0) | |
| Shoulder–Hip | 0.326 (1.1) | 0.141 (2.9) | 0.116 (3.4) | 0.261 (1.5) | 0.505 (0.5) | 0.302 (1.3) | 0.270 (1.5) |
| Head–Hip | 0.484 (0.6) | 0.586 (0.3) | 0.773 (0.1) | 0.540 (0.4) | 0.357 (1.0) | ||
| Hip–Knee | 0.299 (1.3) | 0.787 (0.1) | 0.608 (0.3) | 0.406 (0.8) | 0.236 (1.7) | ||
| Shoulder–Knee | 0.191 (2.2) | 0.742 (0.1) | 0.200 (2.1) | 0.322 (1.2) | |||
| Head–Knee | 0.247 (1.6) | 0.660 (0.2) | 0.390 (0.9) | 0.303 (1.3) | 0.260 (1.5) | ||
*Repeated measures GLM ANOVA of movement patterns with main factors “DBS”, “Vision” and “Adaptation” and their factor interactions. The F-values are presented within the parenthesis.
**Significant differences are marked with bold numbers and trends (p < 0.1) are marked with italics numbers.
Figure 1Body movement coordination (mean values) during different phases of the posturography tests for the PD subjects in DBS OFF mode (a eyes closed; b eyes open), in PD subjects in DBS ON mode (c eyes closed; d eyes open), in old controls (e eyes closed; f eyes open) and in young controls (g eyes closed; h eyes open). Note how both the older and younger controls retained the same posture in Periods 1 and Period 4 of balance perturbations, showing that they quickly adapt. The postural strategy in patients with PD took longer to finalize, mostly with DBS OFF and when standing with eyes closed.
Group, vision and adaptation effect on the body movement pattern.
| GLM ANOVA Statistics*,** | Group | Vision | Adaptation | Group × Vision | Group × Adaptation | Vision × Adaptation | Group × Vision × Adaptation |
|---|---|---|---|---|---|---|---|
| Head–Shoulder | 0.160 (2.0) | 0.199 (1.8) | 0.425 (0.7) | 0.102 (2.9) | |||
| Shoulder–Hip | 0.251 (1.4) | 0.113 (2.7) | 0.278 (1.2) | ||||
| Head–Hip | 0.167 (2.1) | 0.108 (2.8) | 0.200 (1.7) | 0.117 (2.7) | |||
| Hip–Knee | 0.455 (0.6) | 0.499 (0.5) | 0.290 (1.2) | 0.986 (0.0) | 0.189 (1.8) | 0.134 (2.4) | 0.417 (0.7) |
| Shoulder–Knee | 0.423 (0.7) | 0.599 (0.3) | 0.109 (2.8) | 0.415 (0.7) | 0.354 (0.9) | 0.105 (2.9) | 0.420 (0.7) |
| Head–Knee | 0.595 (0.3) | 0.360 (0.9) | 0.246 (1.4) | 0.331 (1.0) | 0.116 (2.7) | 0.301 (1.1) | |
| Head–Shoulder | 0.659 (0.2) | 0.297 (1.1) | |||||
| Shoulder–Hip | 0.979 (0.0) | 0.524 (0.4) | 0.445 (0.6) | 0.172 (2.0) | |||
| Head–Hip | 0.407 (0.7) | 0.432 (0.6) | 0.635 (0.2) | 0.399 (0.7) | |||
| Hip–Knee | 0.332 (1.0) | 0.523 (0.4) | 0.282 (1.2) | 0.683 (0.2) | 0.239 (1.5) | 0.276 (1.3) | |
| Shoulder–Knee | 0.234 (1.5) | 0.336 (1.0) | 0.499 (0.5) | 0.573 (0.3) | 0.694 (0.2) | 0.390 (0.8) | 0.379 (0.8) |
| Head–Knee | 0.324 (1.0) | 0.290 (1.2) | 0.205 (1.7) | 0.503 (0.5) | 0.684 (0.2) | 0.308 (1.1) | 0.357 (0.9) |
| Head–Shoulder | 0.915 (0.0) | 0.426 (0.7) | 0.171 (2.0) | 0.682 (0.2) | 0.245 (1.4) | ||
| Shoulder–Hip | |||||||
| Head–Hip | 0.130 (2.4) | 0.114 (2.6) | 0.135 (2.4) | 0.198 (1.7) | |||
| Hip–Knee | 0.543 (0.4) | 0.747 (0.1) | 0.245 (1.4) | 0.525 (0.4) | 0.115 (2.6) | ||
| Shoulder–Knee | 0.446 (0.6) | 0.919 (0.0) | 0.165 (2.0) | ||||
| Head–Knee | 0.353 (0.9) | 0.795 (0.1) | 0.233 (1.5) | ||||
| Head–Shoulder | 0.224 (1.5) | 0.542 (0.4) | 0.257 (1.3) | ||||
| Shoulder–Hip | 0.540 (0.4) | 0.916 (0.0) | 0.467 (0.5) | 0.804 (0.1) | |||
| Head–Hip | 0.544 (0.4) | 0.139 (2.3) | 0.962 (0.0) | 0.134 (2.4) | 0.217 (1.6) | ||
| Hip–Knee | 0.488 (0.5) | 0.228 (1.5) | 0.655 (0.2) | 0.463 (0.6) | 0.449 (0.6) | ||
| Shoulder–Knee | 0.399 (0.7) | 0.748 (0.1) | 0.358 (0.9) | 0.198 (1.7) | |||
| Head–Knee | 0.563 (0.3) | 0.600 (0.3) | 0.161 (2.1) | 0.239 (1.4) | 0.240 (1.4) | ||
| Head–Shoulder | 0.120 (2.5) | 0.750 (0.1) | 0.455 (0.6) | 0.200 (1.7) | 0.394 (0.7) | ||
| Shoulder–Hip | 0.585 (0.3) | 0.367 (0.8) | 0.273 (1.2) | ||||
| Head–Hip | 0.689 (0.2) | 0.270 (1.3) | 0.520 (0.4) | 0.121 (2.5) | 0.223 (1.5) | ||
| Hip–Knee | 0.731 (0.1) | 0.115 (2.6) | 0.177 (1.9) | 0.140 (2.3) | 0.118 (2.6) | ||
| Shoulder–Knee | 0.311 (1.1) | 0.169 (2.0) | 0.129 (2.4) | 0.185 (1.8) | |||
| Head–Knee | 0.202 (1.7) | 0.222 (1.5) | 0.177 (1.9) | 0.267 (1.3) | 0.300 (1.1) | ||
*Repeated measures GLM ANOVA of movement patterns with main factors “Group”, “Vision” and “Adaptation” and their factor interactions.
**Significant differences are marked with bold numbers and trends (p < 0.1) are marked with italics numbers.
Vision and adaptation effects on body movement coordination.
| GLM ANOVA statistics*,** | Vision | Adaptation | Vision × Adaptation |
|---|---|---|---|
| Head–Shoulder | 0.819 (0.1) | 0.154 (2.7) | 0.171 (2.4) |
| Shoulder–Hip | 0.174 (2.4) | 0.221 (1.9) | 0.286 (1.4) |
| Head–Hip | 0.142 (2.9) | 0.100 (3.8) | 0.451 (0.6) |
| Hip–Knee | 0.551 (0.4) | ||
| Shoulder–Knee | 0.222 (1.9) | 0.255 (1.6) | |
| Head–Knee | 0.141 (2.9) | 0.279 (1.4) | |
| Head–Shoulder | 0.576 (0.3) | 0.136 (2.7) | 0.189 (2.0) |
| Shoulder–Hip | 0.174 (2.2) | 0.560 (0.4) | |
| Head–Hip | 0.470 (0.6) | 0.193 (2.0) | |
| Hip–Knee | 0.580 (0.3) | 0.517 (0.5) | |
| Shoulder–Knee | 0.260 (1.5) | ||
| Head–Knee | 0.227 (1.7) | 0.247 (1.6) | |
| Head–Shoulder | 0.185 (1.9) | ||
| Shoulder–Hip | 0.930 (0.0) | 0.116 (2.8) | |
| Head–Hip | 0.790 (0.1) | ||
| Hip–Knee | 0.574 (0.3) | 0.445 (0.6) | 0.142 (2.4) |
| Shoulder–Knee | 0.808 (0.1) | 0.461 (0.6) | 0.395 (0.8) |
| Head–Knee | 0.828 (0.0) | 0.392 (0.8) | 0.459 (0.6) |
| Head–Shoulder | 0.212 (1.6) | 0.337 (1.0) | 0.213 (1.6) |
| Shoulder–Hip | 0.219 (1.6) | 0.463 (0.6) | |
| Head–Hip | 0.140 (2.3) | 0.418 (0.7) | 0.347 (0.9) |
| Hip–Knee | 0.137 (2.4) | ||
| Shoulder–Knee | |||
| Head–Knee | 0.101 (2.9) | ||
*Repeated measures GLM ANOVA of movement patterns with main factors “Vision” and “Adaptation” and their factor interactions. The F-values are presented within the parenthesis.
**Significant differences are marked with bold numbers and trends (p < 0.1) are marked with italics numbers.
Movement pattern changes in different groups and conditions between quiet stance and vibration period 1 and between vibration period 1 and period 4 during tests with eyes closed and eyes open.
| Body movement coordination*,** | Quiet stance vs. Vibration Period 1 | Vibration Period 1 vs. Period 4 | ||
|---|---|---|---|---|
| Eyes closed | Eyes open | Eyes closed | Eyes open | |
| Head–Shoulder | 0.570 (0.98) | 0.922 (1.00) | 0.232 (1.01) | |
| Shoulder–Hip | 0.641 (1.02) | 0.557 (1.11) | 0.813 (1.01) | |
| Head–Hip | 0.945 (1.00) | 0.469 (1.06) | 0.432 (1.14) | |
| Hip–Knee | 0.313 (1.15) | 0.375 (1.02) | 0.131 (1.03) | |
| Shoulder–Knee | 0.250 (1.12) | |||
| Head–Knee | 0.203 (1.11) | 0.232 (1.15) | ||
| Head–Shoulder | 0.375 (0.95) | 0.492 (1.00) | ||
| Shoulder–Hip | 0.922 (0.99) | 0.432 (1.09) | ||
| Head–Hip | 0.432 (1.06) | 0.625 (1.13) | 0.160 (1.08) | |
| Hip–Knee | 0.193 (1.09) | |||
| Shoulder–Knee | 0.129 (1.27) | 0.275 (1.09) | ||
| Head–Knee | 0.193 (1.26) | 0.426 (1.27) | 0.131 (1.15) | |
| Head–Shoulder | 0.517 (1.00) | 0.120 (1.01) | ||
| Shoulder–Hip | 0.145 (1.07) | 0.528 (0.98) | ||
| Head–Hip | 0.821 (0.98) | |||
| Hip–Knee | 0.353 (0.99) | 0.821 (0.93) | ||
| Shoulder–Knee | 0.190 (1.04) | 0.712 (1.05) | ||
| Head–Knee | 0.190 (1.05) | 0.963 (1.04) | ||
| Head–Shoulder | 0.560 (0.99) | 0.252 (1.01) | ||
| Shoulder–Hip | 0.353 (1.01) | 0.895 (1.00) | ||
| Head–Hip | 0.263 (1.01) | 0.937 (1.02) | ||
| Hip–Knee | 0.353 (1.04) | 0.411 (0.98) | ||
| Shoulder–Knee | 0.107 (1.08) | |||
| Head–Knee | 0.220 (1.06) | 0.148 (0.95) | ||
*The quotient value between quiet stance and period 1 and between period 1 and period 4 are presented within the parenthesis. A quotient value above 1 signifies an increased synchronicity between the movements made at body sites compared.
**Bonferroni corrected significant differences are marked with bold numbers and trends (p < 0.1) are marked with italics numbers.
Characteristics of patients with Parkinson’s disease (PD).
| Characteristics | Median (min–max) |
|---|---|
| Age (years) | 66 (59–69) |
| Sex | 9 men, 1 woman |
| Disease duration (years) | 18 (10–22) |
| Medication as | 416 (294–989) |
| DBS treatment duration (months) | 37 (15–70) |
| Right | |
| Amplitude (V) | 3.3 (2.5–4.3) |
| Pulse width (µs) | 60 (60–90) |
| Frequency (Hz) | 145 (100–185) |
| Amplitude (V) | 3.4 (2.2–4.3) |
| Pulse width (µs) | 60 (60–90) |
| Frequency (Hz) | 130 (100–185) |
| Right (mm) | |
| Lateral | 11.7 (10.4–13.1) |
| Posterior | 3.4 (3.0–4.0) |
| Inferior | 2.1 (1.0–5.6) |
| Left (mm) | |
| Lateral | 11.4 (9.6–13.0) |
| Posterior | 3.5 (3.3–5.2) |
| Inferior | 2.6 (1.2–4.2) |
| Intercommissural line (mm) | 24.8 (23.5–25.6) |
| DBS OFF | |
| Item 20 and 21 (tremor) | 2.3 (0–8.1) |
| Total score | 41.0 (35.0–83.5) |
| DBS ON | |
| Item 20 and 21 (tremor) | 0 (0–0) |
| Total score | 21.5 (11.0–30.5) |
| DBS OFF | 42 (27–50) |
| DBS ON | 50 (41–52) |
| A history of falls during the past 6 months, n (%) | 7 (70%) |
aCalculated equivalent doses of Levodopa according to the method presented by Østergaard et al.[49], and Calne[50]. All participants received L-dopa in their daily life, and 7/10 subjects received also dopamine agonists.
bUPDRS part III: Unified Parkinson’s disease Rating Scale, motor examination. The maximum total score is 108 points (higher scores = more severe motor symptoms). The Berg Balance scale has a scoring range from 0–56 points (higher scores = better). The evaluations were performed in anti-PD medication OFF state. All anti-Parkinsonian medications were withdrawn overnight for 10–12 h. The UPDRS assessments and balance assessments were done at the same occasion as the assessments of posture.